Novartis and Gates Foundation Ink Sickle Cell Gene Therapy Pact

Seeking Low-Cost Practical Option For Sub-Saharan Africa

Sickle Cells Blocking Blood Flow - isolated on white
Novartis looking to tackle SCD with gene therapy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Gene Therapies

More from Advanced Therapies